Liftstream is an executive search recruitment company in the life sciences sector
Rare Disease biotech Aldeyra raises $25m in IPO
Authored by James Sheppard
Kite Pharma expands senior management and board
Authored by James Sheppard
Posted in Orphan Drugs and Rare Diseases, Recruitment Market
Tagged Arie Belldegrun, Arno Therapeutics, California, CEO, CFO, COO, Cougar Biotechnology, Cynthia Butitta, FDA, immunotherapy, J&J, Jonathan Peacock, Kite Pharma, orphan drug designation, regulatory affairs, Rizwana Sproule, T-Cell Therapy, Teva
Leave a comment
Johnson & Johnson grows prostate cancer franchise with Aragon purchase
Authored by James Sheppard
Pharma marries VCs to give birth to Biotechs
Authored by Karl Simpson
Posted in M&A Finance and Funding, Pharmaceutical business
Tagged Amgen, Atlas Ventures, Avalon Ventures, biotech, Bruce Booth, celgene, collaborative business models, Francesco De Rubertis, Fund IX, GSK, Index Ventures, J&J, Johnson & Johnson, Kevin Johnson, Large Pharma, LSD, Nimbus Discovery, Novartis, Pangenetics, Paul Stoffels, pharma, Quanticel, R&D, Sanofi, Shire HGT, SR One, Third Rock Ventures, Tibotec, venture capital, Versant Ventures, Warp Drive Bio
Leave a comment
Medical Device Industry Engineering Emerging Markets Future
Authored by James Sheppard
Posted in Medical Device
Tagged Alpha X-Ray Technologies, Brazil, BRIC, china, China Bord Blood, Covidien, Essex Woodland, EU, GE Healthcare, India, Indonesia, Investment, J&J, Japan, Johnson & Johnson, Kanghui Holdings, LifeTech Scientific Corp, Medical Device, Meditronics, Medtronic, Microport, N-11, Omar Ishrak, Philips Healthcare, Ronald De Jong, Russia, Shanghai, Taiwan, us, Venezuela, venture capital
Leave a comment
European Society for Medical Oncology (ESMO) Congress 2012 Highlights
The European Society for Medical Oncology (ESMO) recently held its annual congress in Vienna, Austria. The congress was a flood with a variety of new and updated clinical data about a number of cancer drugs currently in development. The congress was a blend of big pharma and small innovative biotech’s presenting a wide array of data. Below, Liftstream looks at some of the highlights from the congress.
Posted in General, Pharmaceutical business
Tagged Ariad, breast cancer, celgene, CytRx, Dendreon, ESMO, ESMO 2012, Genentech, GSK, Herceptin, J&J, Nektar Therapeutics, oncology, Orion Pharma, Pfizer, prostate cancer, Roche, T-DM1, Velcade
Leave a comment